View in EDS HTML Full Text PDF Full Text

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial.

Saved in:
Bibliographic Details
Title: Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial.
Authors: Baltrusaitis, Kristin1 (AUTHOR) kbaltrus@sdac.harvard.edu, Makanani, Bonus2 (AUTHOR), Tierney, Camlin1 (AUTHOR), Fowler, Mary Glenn3 (AUTHOR), Moodley, Dhayendre4 (AUTHOR), Theron, Gerhard5 (AUTHOR), Nyakudya, Lynette H.6 (AUTHOR), Tomu, Musunga6 (AUTHOR), Fairlie, Lee7 (AUTHOR), George, Kathleen8 (AUTHOR), Heckman, Barbara9 (AUTHOR), Knowles, Kevin9 (AUTHOR), Browning, Renee10 (AUTHOR), Siberry, George K.11 (AUTHOR), Taha, Taha E.12 (AUTHOR), Stranix-Chibanda, Lynda6,13 (AUTHOR), for the PROMISE P1084s Study Team (AUTHOR), Currier, Judith14 (AUTHOR), Luzuriaga, Katherine15 (AUTHOR), Weinberg, Adriana16 (AUTHOR)
Source: BMC Infectious Diseases. 7/20/2022, Vol. 22 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712334
DOI:10.1186/s12879-022-07608-8